Literature DB >> 18227432

Critical contribution of VH-VL interaction to reshaping of an antibody: the case of humanization of anti-lysozyme antibody, HyHEL-10.

Takeshi Nakanishi1, Kouhei Tsumoto, Akiko Yokota, Hidemasa Kondo, Izumi Kumagai.   

Abstract

To clarify the effects of humanizing a murine antibody on its specificity and affinity for its target, we examined the interaction between hen egg white lysozyme (HEL) and its antibody, HyHEL-10 variable domain fragment (Fv). We selected a human antibody framework sequence with high homology, grafted sequences of six complementarity-determining regions of murine HyHEL-10 onto the framework, and investigated the interactions between the mutant Fvs and HEL. Isothermal titration calorimetry indicated that the humanization led to 10-fold reduced affinity of the antibody for its target, due to an unfavorable entropy change. Two mutations together into the interface of the variable domains, however, led to complete recovery of antibody affinity and specificity for the target, due to reduction of the unfavorable entropy change. X-ray crystallography of the complex of humanized antibodies, including two mutants, with HEL demonstrated that the complexes had almost identical structures and also paratope and epitope residues were almost conserved, except for complementary association of variable domains. We conclude that adjustment of the interfacial structures of variable domains can contribute to the reversal of losses of affinity or specificity caused by humanization of murine antibodies, suggesting that appropriate association of variable domains is critical for humanization of murine antibodies without loss of function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18227432      PMCID: PMC2222731          DOI: 10.1110/ps.073156708

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  58 in total

1.  Structural evidence for entropic contribution of salt bridge formation to a protein antigen-antibody interaction: the case of hen lysozyme-HyHEL-10 Fv complex.

Authors:  M Shiroishi; A Yokota; K Tsumoto; H Kondo; Y Nishimiya; K Horii; M Matsushima; K Ogasahara; K Yutani; I Kumagai
Journal:  J Biol Chem       Date:  2001-04-10       Impact factor: 5.157

2.  Small rearrangements in structures of Fv and Fab fragments of antibody D1.3 on antigen binding.

Authors:  T N Bhat; G A Bentley; T O Fischmann; G Boulot; R J Poljak
Journal:  Nature       Date:  1990-10-04       Impact factor: 49.962

3.  High-resolution mapping of the HyHEL-10 epitope of chicken lysozyme by site-directed mutagenesis.

Authors:  L N Kam-Morgan; S J Smith-Gill; M G Taylor; L Zhang; A C Wilson; J F Kirsch
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

4.  Water-mediated protein-DNA interactions: the relationship of thermodynamics to structural detail.

Authors:  C J Morton; J E Ladbury
Journal:  Protein Sci       Date:  1996-10       Impact factor: 6.725

5.  Contribution to antibody-antigen interaction of structurally perturbed antigenic residues upon antibody binding.

Authors:  K Tsumoto; Y Ueda; K Maenaka; K Watanabe; K Ogasahara; K Yutani; I Kumagai
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

6.  Effect of the order of antibody variable regions on the expression of the single-chain HyHEL10 Fv fragment in E. coli and the thermodynamic analysis of its antigen-binding properties.

Authors:  K Tsumoto; Y Nakaoki; Y Ueda; K Ogasahara; K Yutani; K Watanabe; I Kumagai
Journal:  Biochem Biophys Res Commun       Date:  1994-06-15       Impact factor: 3.575

7.  Role of the domain-domain interaction in the construction of the antigen combining site. A comparative study by 1H-15N shift correlation NMR spectroscopy of the Fv and Fab fragments of anti-dansyl mouse monoclonal antibody.

Authors:  H Takahashi; H Tamura; N Shimba; I Shimada; Y Arata
Journal:  J Mol Biol       Date:  1994-10-28       Impact factor: 5.469

8.  Humanization of a mouse anti-human interleukin-6 receptor antibody comparing two methods for selecting human framework regions.

Authors:  K Sato; M Tsuchiya; J Saldanha; Y Koishihara; Y Ohsugi; T Kishimoto; M M Bendig
Journal:  Mol Immunol       Date:  1994-04       Impact factor: 4.407

Review 9.  Interactions of protein antigens with antibodies.

Authors:  D R Davies; G H Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

Review 10.  The role of therapeutic antibodies in drug discovery.

Authors:  L H Stockwin; S Holmes
Journal:  Biochem Soc Trans       Date:  2003-04       Impact factor: 5.407

View more
  20 in total

1.  Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody.

Authors:  Bharat Madan; Baoshan Zhang; Kai Xu; Cara W Chao; Sijy O'Dell; Jacy R Wolfe; Gwo-Yu Chuang; Ahmed S Fahad; Hui Geng; Rui Kong; Mark K Louder; Thuy Duong Nguyen; Reda Rawi; Arne Schön; Zizhang Sheng; Rajani Nimrania; Yiran Wang; Tongqing Zhou; Bob C Lin; Nicole A Doria-Rose; Lawrence Shapiro; Peter D Kwong; Brandon J DeKosky
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-09       Impact factor: 11.205

2.  An insight into the thermodynamic characteristics of human thrombopoietin complexation with TN1 antibody.

Authors:  Shigeki Arai; Chie Shibazaki; Motoyasu Adachi; Eijiro Honjo; Taro Tamada; Yoshitake Maeda; Tomoyuki Tahara; Takashi Kato; Hiroshi Miyazaki; Michael Blaber; Ryota Kuroki
Journal:  Protein Sci       Date:  2016-07-25       Impact factor: 6.725

3.  Antibody VH and VL recombination using phage and ribosome display technologies reveals distinct structural routes to affinity improvements with VH-VL interface residues providing important structural diversity.

Authors:  Maria A T Groves; Lily Amanuel; Jamie I Campbell; D Gareth Rees; Sudharsan Sridharan; Donna K Finch; David C Lowe; Tristan J Vaughan
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

4.  Specific fluorine labeling of the HyHEL10 antibody affects antigen binding and dynamics.

Authors:  Mauro Acchione; Yi-Chien Lee; Morgan E DeSantis; Claudia A Lipschultz; Alexander Wlodawer; Mi Li; Aranganathan Shanmuganathan; Richard L Walter; Sandra Smith-Gill; Joseph J Barchi
Journal:  Biochemistry       Date:  2012-07-16       Impact factor: 3.162

5.  Suppression of antibody-mediated arthritis in mice by Fab fragments of the mediating antibodies.

Authors:  S Yoshino; M Sasahara; Pilaiwanwadee Hutamekalin; K Yamaki; N Mizutani; H Kuramoto
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

6.  Co-transplantation of human hematopoietic stem cells and human breast cancer cells in NSG mice: a novel approach to generate tumor cell specific human antibodies.

Authors:  Anja K Wege; Marcus Schmidt; Elke Ueberham; Marvin Ponnath; Olaf Ortmann; Gero Brockhoff; Jörg Lehmann
Journal:  MAbs       Date:  2014-05-08       Impact factor: 5.857

Review 7.  Ancient species offers contemporary therapeutics: an update on shark VNAR single domain antibody sequences, phage libraries and potential clinical applications.

Authors:  Hejiao English; Jessica Hong; Mitchell Ho
Journal:  Antib Ther       Date:  2020-01-21

8.  Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design.

Authors:  Clara T Schoeder; Samuel Schmitz; Jared Adolf-Bryfogle; Alexander M Sevy; Jessica A Finn; Marion F Sauer; Nina G Bozhanova; Benjamin K Mueller; Amandeep K Sangha; Jaume Bonet; Jonathan H Sheehan; Georg Kuenze; Brennica Marlow; Shannon T Smith; Hope Woods; Brian J Bender; Cristina E Martina; Diego Del Alamo; Pranav Kodali; Alican Gulsevin; William R Schief; Bruno E Correia; James E Crowe; Jens Meiler; Rocco Moretti
Journal:  Biochemistry       Date:  2021-03-11       Impact factor: 3.162

9.  Humanization and characterization of an anti-ricin neutralization monoclonal antibody.

Authors:  Wei-Gang Hu; Junfei Yin; Damon Chau; Laurel M Negrych; John W Cherwonogrodzky
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

10.  Cytokinergic IgE Action in Mast Cell Activation.

Authors:  Heather J Bax; Anthony H Keeble; Hannah J Gould
Journal:  Front Immunol       Date:  2012-08-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.